|
⚲
|
| Keyboard |
| AI Biotechnology LLC
✚
|
|
|---|---|
| CIK # | 0001942670 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001942670] | |
| 4 | [0001942670] | |
| SC 13D | [0001942670] | |
| SC 13G | [0001942670] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| AI Biotechnology LLC | Onkure Therapeutics Inc | [2026-04-07] |
| AI Biotechnology LLC | ZURA Bio Ltd | [2025-05-28] |
| AI Biotechnology LLC | Surrozen Inc/DE | [2025-03-31] |
| AI Biotechnology LLC | VYNE Therapeutics Inc | [2023-11-13] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zura Bio Ltd ZURA
Class A Ordinary Shares
|
2026-02-26 | Buy | 2,000,000 | $6.25 | 12,500,000 |
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Conversion | 3,147,000 | ||
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Conversion | 1,172,410 | ||
|
Upstream Bio Inc UPB
Common Stock
|
2024-10-15 | Buy | 1,175,000 | $17.00 | 19,975,000 |
|
Upstream Bio Inc UPB
Series B Convertible Preferred Stock · derivative
|
2024-10-15 | Conversion | 1,172,410 | ||
|
Upstream Bio Inc UPB
Series A Convertible Preferred Stock · derivative
|
2024-10-15 | Conversion | 3,147,000 | ||
|
Verona Pharma PLC VRNA
Ordinary Shares
|
2022-08-15 | Buy | 4,800,000 | $1.31 | 6,288,000 |